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Co-morbidity is frequently experienced by gout patients
(1) but psychological morbidity associated with gout
remains poorly understood. Given the established asso-
ciation between musculoskeletal pain and mental health
problems (2), it seems plausible that gout is associated
with psychological co-morbidity, such as anxiety or
depression. However, the incidence of these specific psy-
chological co-morbidities in gout populations remains
unknown. We conducted a matched retrospective cohort
study to examine the association between gout and sub-
sequent incident consultation for anxiety or depression in
UK primary care.
Consultation data were available from nine general
practices in North Staffordshire, UK between 2000 and
2011 (3). Consulters aged  18 years who had been
diagnosed with gout between 2000 and 2008 were identi-
fied using Read codes and were frequency matched by
age, gender, year of consultation, and general practice to
four controls without gout. The outcome of interest was
the first consultation with a diagnostic Read code for
anxiety or depression subsequent to the first diagnostic
Read code for gout. Gout patients or controls with a
diagnosis of anxiety or depression before the matching
dates were excluded.
Key characteristics of the gout sample and the
matched controls were examined. These included fac-
tors upon which the cohorts were matched and the
neighbourhood level of deprivation, determined using
the Indices of Multiple Deprivation (IMD) (4). Incident
consultation rates (per 1000 person-years) for anxiety or
depression were calculated for gout and non-gout con-
trols. The proportions consulting for other selected co-
morbidities were also described. Cox regression was
used to model the time to first anxiety or depression
consultation, adjusting initially for the matched factors
and then further adjusting to include deprivation status
and co-morbidities. Outcomes are reported as hazard
ratios (HRs) with 95% confidence intervals (CIs) for
gout cases vs. matched controls.
In total, 1689 gout patients were identified and
matched successfully to 6756 patients without gout.
The mean age of gout patients was 63 years (sd 16);
76% were male. Deprivation status was similar between
those with and without gout, gout patients were more
likely to have all co-morbidities, other than smoking,
than controls.
The incidence rate of depression was 10.8 (95% CI
10.0–11.7) per 1000 person-years for gout cases and
10.0 (95% CI 8.5–11.8) for matched controls. The inci-
dence rate of anxiety was 15.2 (95% CI 14.2–16.2) per
1000 person-years for the gout cases and 16.2 (95% CI
14.3–18.3) for matched controls (Table 1). Unadjusted
HRs in the Cox regression model found no association
between gout and time to consultation for either anxiety
(1.09, 95% CI 0.95–1.25) or depression (0.92, 95% CI
0.77–1.10) compared to matched controls. Adjustment
had little effect on these associations for anxiety (1.01,
95% CI 0.87–1.16) or depression (0.87, 95% CI 0.73–
1.05) (Table 1).
This is the first study of consultation incidence of
psychological co-morbidities in gout. Using a large UK
primary care consultation database, incident gout was not
associated with subsequent consultation for anxiety or
depression. Possible explanations are that the psycholo-
gical burden of pain is lessened during the prolonged
asymptomatic inter-critical periods between gout attacks
in some patients, or that whereas gout predominantly
affects men, women are more likely to consult primary
care for anxiety or depression (5). As such, our study
may simply reflect population norms of consulting beha-
viour (6).
This study provides new evidence of a lack of an
association between common mental health problems
and gout. This was achieved through the use of a large
primary care database with proven validity and used
previously to examine gout patients (3). There are
several limitations of our study: anxiety and depression
are typically under-reported in primary care (7) and
limitations of coding by general practitioners (GPs)
are also highlighted in the low prevalence of other
co-morbidities, such as smoking. However, there is no
reason to suspect that any under-recording of any of
these conditions would differ between those with and
without gout.
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In conclusion, the rates of consultation for anxiety or
depression in UK primary care gout patients were equiva-
lent to their matched counterparts. Further research is
needed using more patient-reported measures of anxiety
and depression and considering gout severity and disease
characteristics.
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Table 1. Incidence rates and hazard ratios (HRs) for the risk of anxiety and depression in gout cases vs. matched controls.
Psychological co-morbidity
Sample
n (%)
Incidence rate per 1000
person-years (95% CI)
Unadjusted HR
(95% CI)
Adjusted HR *
(95% CI)
Adjusted HR †
(95% CI)
Anxiety
Gout 258 (15.3) 15.2 (14.2–16.2) 1.09 (0.95–1.25) 1.10 (0.96–1.26) 1.01 (0.87–1.16)
Non-gout 958 (14.2) 16.2 (14.3–18.3)
Depression
Gout 164 (9.7) 10.8 (10.0–11.7) 0.92 (0.77–1.10) 0.93 (0.78–1.12) 0.87 (0.73–1.05)
Non-gout 640 (9.5) 10.0 (8.5–11.8)
CI, confidence interval.
* Adjusted for age, gender, year of consultation, and general practice.
† Adjusted for age, gender, deprivation status, year of consultation, general practice, and co-morbidities. Adjustment for co-morbidity
in anxiety included: depression, hypertension, hyperlipidaemia, diabetes and alcoholism and non-dependent alcohol abuse.
Adjustment for co-morbidity in depression included: anxiety, hypertension, chronic kidney disease, alcoholism and non-dependent
alcohol abuse and obesity.
258 Letters
www.scandjrheumatol.dk
